Table 2 Clinical and histological characteristics of patients with glioma
| Â | TCGA (RNA-Seq) | GSE16011 | GSE4412 | GSE4271 | ||||
|---|---|---|---|---|---|---|---|---|
LGG | GBM | LGG | GBM | LGG | GBM | LGG | GBM | |
| Â | 516 | 154 | 109 | 159 | 26 | 59 | 24 | 76 |
Sex | ||||||||
 Male | 285 | 99 | 72 | 108 | 6 | 26 | 16 | 52 |
 Female | 230 | 54 | 37 | 51 | 20 | 33 | 8 | 24 |
 Unknown | 1 | 1 |  |  |  |  |  |  |
Age | ||||||||
 Median (LQ-UQ) | 41 (32–53) | 60 (52–70) | 44 (37–55) | 55 (46–64) | 34 (31–41) | 47 (39–61) | 35 (32–43) | 49 (40–55) |
Histology | ||||||||
 Astro. | 194 (37.6%) |  | 29 (24.8%) |  | 8 (30.8%) |  |  |  |
 GBM |  | 154 (100%) |  | 159 (100%) |  | 59 (100%) |  |  |
 Oligoastro. | 130 (25.2%) |  | 28 (23.9%) |  | 7 (26.9%) |  |  |  |
 Oligodendro. | 191 (37.0%) |  | 52 (44.4%) |  | 11 (42.3%) |  |  |  |
 Pilocytic Astro. |  |  |  |  |  |  |  |  |
 Unknown | 1 (0.2%) |  |  |  |  |  |  |  |
Tumor grade | ||||||||
 G1 |  |  |  |  |  |  |  |  |
 G2 | 249 (48.3%) |  | 24 (20.5%) |  |  |  |  |  |
 G3 | 266 (51.6%) |  | 85 (73.7%) |  | 26 (100%) |  | 24 (100%) |  |
 G4 |  | 153 (99.4%) |  | 159 (100%) |  | 59 (100%) |  | 76 (100%) |
 Unknown | 1 (0.1%) | 1 (0.6%) |  |  |  |  |  |  |